- Corporate Officers - P
- Perry Michael S
Insider Trading History of Perry Michael S
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Perry Michael S since 2011.
This trader's CIK number is 1250379.
At the time of last reporting, Perry Michael S was the Director of Arrowhead Pharmaceuticals, Inc.. (stock ticker symbol ARWR).
Also see all insider trading activities at Arrowhead Pharmaceuticals, Inc..
Note that in the past
PERRY MICHAEL S also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Armata Pharmaceuticals, Inc. (APHB) by Perry Michael S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | APHB | 292,592 | $200,002 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Avita Medical, Inc. (RCEL) by Perry Michael S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | RCEL | 0 | $0 | 34,220 | $630,618 | 0 | $0 |
| 2020 | RCEL | 0 | $0 | 74,989 | $2,008,833 | 0 | $0 |
Yearly summary of insider trading at Neorx Corp (PARD) by Perry Michael S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | PARD | 0 | $0 | 7,945 | $6,838 | 14,819 | $0 |
| 2011 | PARD | 0 | $0 | 45,140 | $16,882 | 112,000 | $0 |
Yearly summary of insider trading at Arrowhead Pharmaceuticals, Inc. (ARWR) by Perry Michael S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | ARWR | 0 | $0 | 4,500 | $293,503 | 0 | $0 |
| 2021 | ARWR | 0 | $0 | 4,000 | $304,360 | 0 | $0 |
| 2020 | ARWR | 0 | $0 | 36,000 | $1,298,340 | 77,000 | $268,961 |
| 2019 | ARWR | 0 | $0 | 185,000 | $5,440,000 | 0 | $0 |
Insider trading activities at 4 companies by Perry Michael S:
1. Armata Pharmaceuticals, Inc. (APHB)
2. Avita Medical, Inc. (RCEL)
3. Neorx Corp (PARD)
4. Arrowhead Pharmaceuticals, Inc. (ARWR)
Table 1. Insider trading of Armata Pharmaceuticals, Inc. (APHB) by Perry Michael S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-03-22 | APHB | Buy | 181,820 | 1.10 | 200,002 |
| 2017-06-29 | APHB | Buy | 5,757 | .00 | 0 |
| 2017-09-19 | APHB | Buy | 105,015 | .00 | 0 |
Table 2. Insider trading of Avita Medical, Inc. (RCEL) by Perry Michael S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-09-01 | RCEL | Sale | 11,220 | 20.68 | 232,029 |
| 2021-06-02 | RCEL | Sale | 23,000 | 17.33 | 398,589 |
| 2020-09-16 | RCEL | Sale | 9,000 | 27.41 | 246,690 |
| 2020-09-15 | RCEL | Sale | 23,769 | 27.23 | 647,229 |
| 2020-09-14 | RCEL | Sale | 15,092 | 26.99 | 407,333 |
| 2020-09-10 | RCEL | Sale | 7,128 | 26.26 | 187,181 |
| 2020-09-11 | RCEL | Sale | 20,000 | 26.02 | 520,400 |
Table 3. Insider trading of Neorx Corp (PARD) by Perry Michael S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-03-27 | PARD | Sale | 1,599 | .83 | 1,330 |
| 2012-03-26 | PARD | Option Ex | 2,800 | .00 | 0 |
| 2012-02-16 | PARD | Sale | 6,346 | .87 | 5,508 |
| 2012-02-15 | PARD | Option Ex | 12,019 | .00 | 0 |
| 2011-04-13 | PARD | Sale | 45,140 | .37 | 16,882 |
| 2011-04-09 | PARD | Option Ex | 112,000 | .00 | 0 |
Table 4. Insider trading of Arrowhead Pharmaceuticals, Inc. (ARWR) by Perry Michael S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-01-03 | ARWR | Sale | 4,500 | 65.22 | 293,503 |
| 2021-01-04 | ARWR | Sale | 4,000 | 76.09 | 304,360 |
| 2020-05-14 | ARWR | Option Ex | 77,000 | 3.49 | 268,961 |
| 2020-05-12 | ARWR | Sale | 36,000 | 36.06 | 1,298,340 |
| 2019-09-09 | ARWR | Sale | 100,000 | 28.90 | 2,890,000 |
| 2019-09-11 | ARWR | Sale | 85,000 | 30.00 | 2,550,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Perry Michael S
(Director of Arrowhead Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.